Colistina en el tratamiento de infecciones por Pseudomonas aeruginosa y Acinetobacter baumannii extensivamente resistentes (XDR) en un hospital de tercer nivel [Colistin-based treatment for extensively drug resistant (XDR) Pseudomonas aeruginosa and Acinetobacter baumannii infection at a third level hospital]
| dc.date.accessioned | 2023-04-05T12:45:45Z | |
| dc.date.available | 2023-04-05T12:45:45Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Objective: To describe the clinical response and overall mortality of Colistin in infections by Pseudomonas XDR and Acinetobacter XDR at the Hospital Nacional Arzobispo Loayza in Lima, Peru. Methods: Observational, descriptive, retrospective study. Records of all patients > 18 years old, from June 2014 to June 2016, who had infection by Pseudomonas XDR or Acinetobacter XDR confirmed by culture, and who received colistin, were included. A univariate analysis of the general characteristics of the patients was performed; a bivariate analysis with a Chi2, t-student or ANOVA test as appropriate, and the factors associated with mortality were also determined. Results: 56 patient records were included; the median age was 46,5 [31,5 to 63,5]. The Culture was positive for Pseudomonas XDR in 48,2% and for Acinetobacter XDR in 51,8%. The favorable clinical response was 85,7% at 15 days and 78,6% at 30 days. In-hospital mortality at 30 days was 21,4%, ICU mortality was 30,8% and nephrotoxicity was 5,4%. Conclusions: Colistin combined with another antimicrobial had a favorable clinical response in infection with Pseudomonas XDR and Acinetobacter XDR. © 2020 Medicinska Naklada Zagreb. All rights reserved. | |
| dc.identifier.issn | 1239392 | |
| dc.identifier.uri | https://doi.org/10.22354/in.v24i4.876 | |
| dc.identifier.uri | http://146.190.124.33/handle/123456789/5808 | |
| dc.language.iso | spa | es_ES |
| dc.publisher | Asociacion Colombiana de Infectologia | es_ES |
| dc.source | Journal of Clinical and Experimental Dentistry; Vol. 14 Núm. 7 | |
| dc.title | Colistina en el tratamiento de infecciones por Pseudomonas aeruginosa y Acinetobacter baumannii extensivamente resistentes (XDR) en un hospital de tercer nivel [Colistin-based treatment for extensively drug resistant (XDR) Pseudomonas aeruginosa and Acinetobacter baumannii infection at a third level hospital] | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.type.version | info:eu-repo/semantics/publishedVersion |